AGTC Lands $37.5M Series B
November 21, 2012- Share:
Applied Genetic Technologies, a Gainesville, Fla.-based biotech company, has closed on $37.5 million in Series B funding. According to the company’s website, it seeks to “identify diseases which can be treated by delivery of a known gene and for which no other adequate treatments are available.” The round was led by Alta Partners and S.R. One, with participation from Osage University Partners, InterWest, Intersouth Partners and MedImmune Ventures.
- Share:
-
-
-
-